Great question:
    We have been taking this on a case-by-case basis. Though IIIA patients have a favorable prognosis, there are some patients that have a more worrisome feature than the “average IIIA”. For those patients, a detailed risk/benefit discussion is essential, and the patient would be made aware of the data (not including IIIA).

    Latest Activity